Posted by Ella Flemyng (Methods Implementation Coordinator) on 14 October 2019.

Cochrane Methods is pleased to welcome Dr Tianjing Li to the Methods Executive!

Tianjing Li is an Associate Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, USA, and currently based at the Department of Ophthalmology, School of Medicine, University of Colorado Denver, USA. As well as Co-Convening the Cochrane Comparing Multiple Interventions Methods Group, Tianjing has worked with Cochrane in various capacities over the last 15 years, including as Associate Director of Cochrane United States from 2012 to 2018, serving on the Centre Director Executive from 2016-2018, and as Coordinating Editor for Cochrane Eyes and Vision. She is also an Associate Scientific Editor of the recently launched Cochrane Handbook for Systematic Reviews of Interventions.

Outside of Cochrane, Tianjing serves as a Co-Editor-in-Chief for the journal Trials and the Reviews Editor for JAMA Ophthalmology. She is an elected member of the Society for Research Synthesis Methodology and was awarded the Society's inaugural Early Career Award in 2016. She has taught numerous courses and workshops internationally on methods for systematic review, clinical trial, and epidemiology, including the Risk of Bias 2 tool and network meta-analysis, two foci that require robust implementation across Cochrane.

Tianjing’s research interests span the scope of more than half of the Cochrane Methods Groups, including network meta-analysis, adverse events, priority setting, bias, patient-reported outcomes, qualitative research, GRADE, rapid reviews, information retrieval, and technology, publishing papers, book chapters, and other pieces on all these topics.

Details on the Methods Executive and members can be found here.

Please help us welcome Tianjing Li to the Cochrane Methods Executive!